TransMedics Updates on Valuation Allowance Release Impacting Fourth Quarter Results TransMedics Group, Inc. provided insights on the effects of releasing a $103.3 million U.S. tax valuation allowance, impacting their fourth-quarter financial results significantly.

TransMedics Updates on Valuation Allowance Release Impacting Fourth Quarter Results #USA #TransMedics #TMDX #organ_transplant #Andover,_Massachusetts

TransMedics Announces New Global Headquarters and Expansion at Assembly Innovation Park in Somerville, Massachusetts TransMedics (Nasdaq: TMDX) signed a long-term lease for a new global headquarters at Assembly Innovation Park in Somerville, Massachusetts, and acquired an adjacent land parcel to create an integrated campus. The facility will house corporate, R&D, and advanced manufacturing functions with a planned relocation on or before January 2028. The Commonwealth proposed performance-based incentives of up to $18 million tied to creating as many as 600 net new full-time jobs from 2026–2031. Somerville offered up to $18 million in TIF tax relief and projects $75 million in new local tax revenue over ten years.

#TMDX TransMedics Announces New Global Headquarters and Expansion at Assembly Innovation Park in Somerville, Massachusetts

www.stocktitan.net/news/TMDX/trans-medics-a...

TransMedics Group Provides Inducement Grants to New Employees Under Listing Rule TransMedics Group, a leader in organ transplant technology, has granted inducement stock options to new employees, enhancing their commitment to innovative solutions.

TransMedics Group Provides Inducement Grants to New Employees Under Listing Rule #USA #stock_options #TransMedics #Andover #TMDX

#TMDX TransMedics Reports Third Quarter 2025 Financial Results

www.stocktitan.net/news/TMDX/trans-medics-r...

News; ( NASDAQ: #TMDX ) 4 Stocks to Load Up on Before Earnings

TransMedics Group shares rose after the FDA granted conditional approval for a clinical trial of its Next-Generation OCS ENHANCE Heart system, designed to improve organ preservation for transplants.

#TMDX #TMDXStock #TMDXNews #TMDXStockNews #TransMedics #TransMedicsStock #TransMedicsNews

TransMedics Announces New Employee Inducement Grants Under NASDAQ Rule 5635 TransMedics Group, Inc. recently reported the granting of stock options and restricted stock units to new employees, fulfilling NASDAQ's inducement requirements.

TransMedics Announces New Employee Inducement Grants Under NASDAQ Rule 5635 #USA #NASDAQ #TransMedics #Andover #TMDX

TransMedics CEO Waleed Hassanein emphasized long-term growth, stating, “We are already ramping up our investments to drive the next several waves of growth that will deliver substantially more top and bottom line growth.”

#TMDX #TransMedics #TMDXStock #TMDXNews #TMDXStockNews
$TMDX

Is TransMedics Stock a Buy After Short-Seller Drama? | The Motley Fool

#TMDX #a3536d04-87af-4e02-8f6a-9e2a6d24c39f #investing

Origin | Interest | Match

#TMDX #FUBO #d5c18edf-b1be-4a5e-8b61-0bad145e4920 #investing

Origin | Interest | Match

#TMDX #PODD #VEEV #OPCH #INSP #BEAM #LFMD #CERT #KRYS #TEM #de58360b-9299-4682-bac3-d7906ea4ff35

Origin | Interest | Match

Kuehn Law Investigates TransMedics Group, Inc. Shareholder Concerns Kuehn Law, a litigation firm, is probing TransMedics Group, Inc. for potential breaches by executives. Essential for shareholders to engage now.

Kuehn Law Investigates TransMedics Group, Inc. Shareholder Concerns #United_States #New_York #Kuehn_Law #TransMedics_Group #TMDX

TransMedics Grants Inducement Options Enhancing Employee Incentives Under NASDAQ Rule 5635(c)(4) TransMedics Group, Inc. has announced the granting of stock options and restricted stock units to bolster employee retention and incentivize performance, successfully aligning with NASDAQ rules.

TransMedics Grants Inducement Options Enhancing Employee Incentives Under NASDAQ Rule 5635(c)(4) #United_States #TransMedics #Andover #TMDX #Organs

Nasdaq (or QQQ) stock chart. Price action building out sideways over last 5 trading sessions.

#StockMarket #QQQ building out sideways over past 5 sessions. Still > 4x ATR above 50-day, which is extended in my book. Monday's gap down was bought up, so still appetite out there. Many leaders also showing hi tight flag setups.
Current swing longs: #TMDX #GDXU #IONQ #MBOT #EUAD

www.fool.com/investing/2025/05/14/2-b...

#TMDX #EXAS […]

[Original post on fool.com]

#StockMarket Big gap up this morning on China trade de-escalation. As swing traders, gap ups are chances to "take a little off the table" and book some profits. #QQQ extended here... will we see "sell the news"?
Current swing longs: #TMDX, #MBOT, #SATL, #RGTI (earnings after close), #IONQ, #EUAD

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations!

PM Top Unusual Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #MSTR 50% OTM
2. #TSLA 47% OTM
3. #WOLF 34% OTM
4. #TMDX 30% OTM
5. #PLTR 25% OTM

#OptionFlow #OptionsTrading #Trading

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations!

AM Top Unusual Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #PLTR 40% OTM
2. #WOLF 35% OTM
3. #BULL 32% OTM
4. #TMDX 30% OTM
5. #CRWV 24% OTM

#OptionFlow #OptionsTrading #Trading

Nasdaq stock chart showing current price just below 200-day moving average and 493.62 pivot.

#StockMarket #QQQ at a "moment of truth" here, doing battle with the 200-day moving average (blue ribbon). Uptrend since 4/9 tariff "pause", but no green days w/ above average volume. Dipping toes in long side.
Current swing longs: #TMDX (earnings play), #MBOT, #SATL, #RGTI, #IONQ, #EUAD

TransMedics Reports First Quarter 2025 Financial Results TransMedics (NASDAQ: TMDX) reported strong Q1 2025 financial results with total revenue of $143.5 million, up 48% year-over-year. The company achieved a net income of $25.7 million ($0.70 per diluted share) and maintained a robust gross margin of 61%. Growth was primarily driven by increased utilization of their Organ Care System (OCS), particularly in Liver and Heart transplants through the National OCS Program. The company owned 21 aircraft and announced plans for a new design center and manufacturing facility in Italy. Based on strong performance, TransMedics raised its full year 2025 revenue guidance to $565-585 million, representing 30% growth at the midpoint. The company ended Q1 with a strong cash position of $310.1 million.

#TMDX TransMedics Reports First Quarter 2025 Financial Results

www.stocktitan.net/news/TMDX/trans-medics-r...

www.fool.com/investing/2025/04/24/1-b...

#TMDX […]

[Original post on fool.com]

TransMedics sceglie Mirandola per il suo primo stabilimento fuori dagli Usa: più di 50 assunzioni L’azienda di Andover, nel Massachusetts, è leader nelle tecnologie per il mantenimento e il monitoraggio degli organi destinati al trapianto: ha rivoluzionato il settore sviluppando l’Organ care syste...

Un distretto italiano di assoluta eccellenza nel settore biomedico e una compagnia che mi piace 🤝

Moat, innovazione, crescita.

Non vorrei essere nei panni di un cliente di Scorpion Capital.
#TMDX

TransMedics Group Investors Urged to Join Class Action Due to Losses Investors of TransMedics Group facing financial losses are encouraged to participate in a class action lawsuit led by Robbins Geller. Deadline is April 15, 2025.

TransMedics Group Investors Urged to Join Class Action Due to Losses #USA #Robbins_Geller #San_Diego #TransMedics #TMDX

Investors Encouraged to Join Class Action Against TransMedics Group, Inc. for Securities Fraud The Schall Law Firm invites investors to join a class action lawsuit against TransMedics Group, Inc. for alleged securities fraud related to misleading statements.

Investors Encouraged to Join Class Action Against TransMedics Group, Inc. for Securities Fraud #USA #Los_Angeles #Schall_Law_Firm #TransMedics #TMDX

TransMedics Investors: Deadline Approaching for Fraud Lawsuit Leadership Attention TransMedics investors: Lead plaintiff deadline for a securities fraud lawsuit is approaching. Don't miss your chance to get compensation.

TransMedics Investors: Deadline Approaching for Fraud Lawsuit Leadership #United_States #New_York #Rosen_Law_Firm #TransMedics #TMDX